Angiodynamics (ANGO) Invested Capital (2011 - 2026)

Angiodynamics (ANGO) has 16 years of Invested Capital data on file, last reported at $173.4 million in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital fell 9.18% year-over-year to $173.4 million; the trailing twelve-month figure through Feb 2026 stood at $173.4 million (down 9.18% YoY), and the FY2025 full-year result was $183.0 million, down 11.0% from the prior year.
• Invested Capital for Q1 2026 stood at $173.4 million, down from $176.3 million in the prior quarter.
• Across five years, Invested Capital topped out at $449.5 million in Q2 2022 and bottomed at $173.4 million in Q1 2026.
• The 5-year median for Invested Capital is $228.2 million (2024), against an average of $301.6 million.
• The widest annual swing landed in 2022, when Invested Capital climbed 2.28%; it then plunged 53.44% in 2024.
• A 5-year view of Invested Capital shows it stood at $417.7 million in 2022, then fell by 1.7% to $410.6 million in 2023, then plunged by 53.31% to $191.7 million in 2024, then decreased by 8.03% to $176.3 million in 2025, then dropped by 1.69% to $173.4 million in 2026.
• The last three Invested Capital figures came in at $173.4 million (Q1 2026), $176.3 million (Q4 2025), and $178.9 million (Q3 2025), per Business Quant data.

Peer Comparison